To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma

NCT07179484 · clinicaltrials.gov ↗

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: CT041 autologous CAR T-cell injection

Sponsor

Beijing GoBroad Hospital